Late Effects of Chemotherapy on Patient-Reported Neuropathy, Balance Problems, and Fall Outcomes Among Older Breast Cancer Survivors
Spätfolgen der Chemotherapie auf patientenberichtete Neuropathie, Gleichgewichtsprobleme und Stürze bei älteren Brustkrebsüberlebenden
JCO Oncology Practice · 2026-11 · 22 (11) · 1935-1945
DOI: 10.1200/op-25-00904 ↗Auf einen Blick
Bei älteren Brustkrebsüberlebenden war eine Taxan-Chemotherapie mit häufiger berichteter Neuropathie und mehr Gleichgewichtsproblemen verbunden, nicht jedoch mit Stürzen.
Fragestellung
Wie ist die Langzeitwirkung einer Taxan-Chemotherapie auf patientenberichtete Neuropathie, Gleichgewichtsprobleme und Stürze bei älteren Brustkrebsüberlebenden?
Methode
Analyse von Texas Cancer Registry-Medicare-Daten; Fragebögen zwischen April 2018 und Oktober 2019; multivariable logistische Regression und Rao-Scott-χ2-Tests.
Ergebnisse
1.493 Brustkrebsüberlebende. Chemotherapie: 61,8 % mit Neuropathie vs. 36,0 % ohne; Paclitaxel 73,3 % vs. Docetaxel 55,7 %. Taxan und Stürze: aOR 1,2 (95 %-KI 0,83–1,64); Taxan und Gleichgewichtsprobleme: aOR 1,6 (95 %-KI 1,13–2,24).
Schlussfolgerung der Autor:innen
Ältere Brustkrebsüberlebende nach Taxan-Chemotherapie berichteten häufiger Neuropathie und Gleichgewichtsprobleme, aber nicht mehr Stürze.
Kernaussagen
- Neuropathie häufiger nach Chemotherapie: 61,8 % vs. 36,0 %
- Taxan nicht signifikant mit Stürzen assoziiert
- Taxan mit mehr Gleichgewichtsproblemen assoziiert: aOR 1,6
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift JCO Oncology Practice, 2026-11. Verfasst von Inimfon Jackson und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX. Hauptthemen laut MEDLINE: Breast Neoplasms, Cancer Survivors, Accidental Falls, Postural Balance. Die Arbeit nennt 51 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
PURPOSE Late effects of chemotherapy in older breast cancer (BC) survivors remain understudied. We evaluated the long-term impact of taxane chemotherapy on patient-reported neuropathy, balance problems, and falls among older BC survivors. METHODS Using Texas Cancer Registry-Medicare linked data, BC survivors age 65 years or older at diagnosis, with local or regional disease diagnosed between 2012 and 2013 were identified. Survivors completed questionnaires including patient-reported outcomes and clinical characteristics between April 2018 and October 2019. Rao-Scott chi-square tests and multivariable logistic regression models evaluated associations between taxane chemotherapy and neuropathy in the past 7 days, and balance problems and fall outcomes in the past 12 months. RESULTS Among 1,493 BC survivors, the majority were non-Hispanic White (80.8%), had hormone receptor–positive BC (78.1%), and had localized disease (75.6%). 26.5% received chemotherapy, and 89% of those received a taxane. Survivors who received chemotherapy were more likely to report neuropathy (61.8% v 36.0%, P < .01). Those who received paclitaxel had worse neuropathy than survivors treated with docetaxel (73.3% v 55.7%, P < .01). Although taxane use was not significantly associated with falls (adjusted odds ratio [aOR], 1.2 [95% CI, 0.83 to 1.64]), those treated with a taxane were more likely to report balance problems than those who did not receive chemotherapy (aOR, 1.6 [95% CI, 1.13 to 2.24]). Although Black BC survivors were more likely to report neuropathy (aOR, 1.8 [95% CI, 1.10 to 3.07]), Hispanic (aOR, 1.5 [95% CI, 1.01 to 2.31]) survivors were more likely to receive a provider intervention to prevent falls or treat balance problems relative to White survivors. CONCLUSION Older BC survivors who received taxane chemotherapy were more likely to report neuropathy and balance problems but not falls. Future research should evaluate effective fall prevention and balance interventions in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
- Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX.
- Division of Cancer Prevention and Population Sciences, Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX.
- Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX.
- Department of Internal Medicine, Division of Geriatric and Palliative Medicine, University of Texas Houston McGovern Medical School, Houston, TX.
- Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
ORCID-Profile: Inimfon Jackson, Susan K Peterson, Mariana Chavez-MacGregor, Sharon H Giordano
Zitieren
APA
Jackson, I., Liao, K. P., Peterson, S. K., Li, L., Zorzi, D., Holmes, H. M., Chavez-MacGregor, M., & Giordano, S. H. (2026). Late Effects of Chemotherapy on Patient-Reported Neuropathy, Balance Problems, and Fall Outcomes Among Older Breast Cancer Survivors. JCO Oncology Practice, 22(11), 1935-1945. https://doi.org/10.1200/op-25-00904
Vancouver
Jackson I, Liao KP, Peterson SK, Li L, Zorzi D, Holmes HM, et al. Late Effects of Chemotherapy on Patient-Reported Neuropathy, Balance Problems, and Fall Outcomes Among Older Breast Cancer Survivors. JCO Oncology Practice. 2026;22(11):1935-1945. doi:10.1200/op-25-00904
BibTeX
@article{Jackson2026,
author = {Jackson, Inimfon and Liao, Kai-Ping and Peterson, Susan K and Li, Liang and Zorzi, Daria and Holmes, Holly M and Chavez-MacGregor, Mariana and Giordano, Sharon H},
title = {Late Effects of Chemotherapy on Patient-Reported Neuropathy, Balance Problems, and Fall Outcomes Among Older Breast Cancer Survivors},
journal = {JCO Oncology Practice},
year = {2026},
volume = {22},
number = {11},
pages = {1935--1945},
doi = {10.1200/op-25-00904}
}
EUVIMED